(S1 (S (NP (NP (NP (NN mTOR) (NN function)) (PP (IN in) (NP (JJ skeletal) (NN muscle) (NN hypertrophy)))) (: :) (NP (NP (VBN increased) (JJ ribosomal) (NN RNA)) (PP (IN via) (NP (NN cell) (NN cycle) (NNS regulators)))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ potential) (JJ downstream) (NNS functions)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ mammalian) (NN target)) (PP (IN of) (NP (NP (NP (NN rapamycin)) (PRN (-LRB- -LRB-) (NP (NN mTOR)) (-RRB- -RRB-))) (VP (VBG signaling) (PP (IN during) (NP (NN myotube) (NN hypertrophy))))))))))))))) (. .)))
(S1 (S (S (NP (ADJP (RB Terminally) (VBN differentiated)) (NNS myotubes)) (VP (VBD were) (VP (NN serum) (VBN stimulated) (PP (IN for) (NP (QP (CD 3) (, ,) (CD 6) (, ,) (CD 12) (, ,) (CD 24) (, ,) (CC and) (CD 48)) (NN h)))))) (. .)))
(S1 (S (S (NP (DT This) (NN treatment)) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (JJ significant) (NN myotube) (NN hypertrophy)) (PRN (-LRB- -LRB-) (NP (NN protein/DNA)) (-RRB- -RRB-))) (CC and) (NP (NP (VBN increased) (NN RNA) (NN content)) (PRN (-LRB- -LRB-) (NP (NN RNA/DNA)) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (DT no) (NNS changes)) (PP (IN in) (NP (NP (NN DNA) (NN content)) (CC or) (NP (NP (NNS indices)) (PP (IN of) (NP (NN cell) (NN proliferation)))))))))) (. .)))
(S1 (S (S (PP (IN During) (NP (NN myotube) (NN hypertrophy))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN RNA) (NN content)))) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN tumor) (NN suppressor) (NN protein) (NN retinoblastoma) (-LRB- -LRB-) (NN Rb) (-RRB- -RRB-) (NN phosphorylation)))) (CC and) (NP (NP (DT a) (JJ corresponding) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (NP (DT the) (JJ ribosomal) (NN DNA) (NN transcription) (NN factor) (JJ upstream) (NN binding) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN UBF)) (-RRB- -RRB-)))))))))))) (. .)))
(S1 (S (S (NP (NN Serum) (NN stimulation)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN cyclin) (NN D1)) (NN protein) (NN expression))) (PP (IN in) (NP (DT the) (VBN differentiated) (NNS myotubes)))) (PP (IN with) (NP (NP (DT a) (JJ concomitant) (NN increase)) (PP (IN in) (NP (NP (NP (NP (NN cyclin) (NN D1-dependent) (JJ cyclin-dependent) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN CDK)) (-RRB- -RRB-))) (CD -4) (NN activity)) (PP (IN toward) (NP (NN Rb))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NNS increases)) (PP (IN in) (NP (NP (NN myotube) (NN hypertrophy)) (CC and) (NP (NN RNA) (NN content))))) (VP (VBD were) (VP (VBN blocked) (PP (IN by) (NP (NP (NN rapamycin) (NN treatment)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBD prevented) (NP (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN cyclin) (NN D1)) (NN protein) (NN expression)))) (, ,) (NP (NN CDK-4) (NN activity)) (, ,) (NP (NN Rb) (NN phosphorylation)) (, ,) (CC and) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN UBF) (NN availability))))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS findings)) (VP (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NN mTOR)))) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN for) (NP (NN myotube) (NN hypertrophy)))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN mTOR)))) (VP (VBZ is) (PP (IN in) (NP (NN part))) (S (VP (TO to) (VP (VB modulate) (NP (NN cyclin) (NN D1-dependent) (NN CDK-4) (NN activity)) (PP (IN in) (NP (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN Rb)))) (CC and) (NP (JJ ribosomal) (NN RNA) (NN synthesis))))))))))))) (. .)))
(S1 (S (S (PP (IN On) (DT the) (NN basis) (IN of) (NP (DT these) (NNS results))) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (JJ common) (JJ molecular) (NNS mechanisms)) (VP (VBP contribute) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN myotube) (NN hypertrophy)) (CC and) (NP (NN growth)))))) (PP (IN during) (NP (NP (DT the) (NN G1) (NN phase)) (PP (IN of) (NP (DT the) (NN cell) (NN cycle)))))))))) (. .)))
